Betamethasone acetate is an odorless white or sometime off-white powder that solidifies at about 165°C, decays and melts at about 200°C to 220°C. It does not get dissolved in water and is insoluble, but gets easily dissolved in acetone, chloroform and alcohol. Betamethasone acetate’s chemical formula is C24H31FO6 with a molecular weight of 434.50. By chemical nature, it is 9-Fluoro-11β, 17, 21-trihydroxy-16β-methylpregna-1, 4-diene-3, 20-dione 21-acetate.
Globally, the market of betamethasone acetate is priced at US$ 421.4 Mn in the 2022 and is anticipated to show a Compounded Annual Growth Rate of 4.8% in the predicted period from 2022 to 2030.
Get a comprehensive report summary that describes the Market value and forecast along with methodology.
Request a Sample Report @ https://www.coherentmarketinsights.com/insight/request-sample/5481
Why Acquire?
– Add credibility and authority to your strategies
– Analyze competitors’ offerings
– Holistic view of the worldwide Market (2017-2023)
The growth of the market of betamethasone acetate can get hampered by the existence of the alternative drugs, like the ointment betamethasone dipropionate 0.05%. The main companies are emphasizing on the strategies of inorganic type like launch of product that are alternatives to betamethasone acetate. For example, Lupin is a pharmaceutical company which in March 2020 announced the introduction of the ointment of Betamethasone Dipropionate with USP, 0.05% an alternative to Betamethasone Acetate
Betamethasone acetate is needed in treating many conditions of disease like multiple sclerosis. Therefore, rising incidence of the disease raises the growth of the market in the predicted period. For example, in November, as per an article issued by National Library of Medicine, in the year 2020, the incidence of multiple sclerosis worldwide was 35.9 for every 100,000 people which were raised by 30% in comparison to the year 2013.
Amongst the region, the region of North America is anticipated to control the market in the predicted period which is accredited owing to North America’s held of 37.8% share of the market and rise in application of intramuscular suspension for treating many diseases like ophthalmic disease in the region of North America. For example, as per the data given by CDC (Centers for Disease Control and Prevention, about 12 Mn people above 40 years in the U.S. are impaired visually, which include 1 Mn blind, 3 Mn with vision being corrected and 8 Mn with uncorrected refractive error.
The region of Europe is anticipated to be second as being large in the predicted period, owing to rising incidence of dermatological disease in the region of Europe. For example, in March 2021, as per an article issued by National Library of Medicine, in the year 2021, 185 103 774 people in Europe was dermatologically affected.
The disease of coronavirus or the pandemic of COVID-19 as is known is very communicable and infectious disease which gets transmitted very fast and causes SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) as to the WHO. It affected 44,614,437 people across the world as of 10th October, 2022.
Though, the pandemic of COVID-19 had constructive effect on the market of betamethasone acetate owing to the rising risk of COVID-19. For example, as per the data issued by Washington University School of Medicine, in March 2022, the patients of COVID-19 are at great risk of suffering from the signs and symptoms like, numbness, pain and tingling in feet and hands, which raised the sale of the drug, betamethasone drug, thus successfully affecting the growth of the market of betamethasone worldwide.
On the basis of Distribution Channel, the market of betamethasone acetate is divided into retail pharmacies, hospital pharmacies and online pharmacies. Amongst which, the segment of hospital pharmacies is anticipated to control the market in the predicted period and this is accredited to the rise in number of hospital pharmacies.
Limited Period Offer | Report Available Now at UP TO 45% off Discounted Pricing @
Single User License : https://www.coherentmarketinsights.com/promo/buynow/5481
Multi Users License : https://www.coherentmarketinsights.com/promo/buynow/5481
Corporate Users License : https://www.coherentmarketinsights.com/promo/buynow/5481
Note: Special discounted pricing is only applicable for direct purchase through website. In case of customization, discount would be subject to scope and coverage of the report.
On the basis of application, the market of betamethasone acetate is divided into renal disease, respiratory disease, gastrointestinal disease, dermatological disease, ophthalmic disease and others. The segment of dermatological segment is anticipated to control the market in the predicted period and this is credited to the rise in application of betamethasone acetate drugs in treating skin problems like inflammation.
On the basis of age group, the market of betamethasone acetate is divided into pediatric and geriatric. Amongst which, the market of geriatric is anticipated to control the market in the predicted period and this is accredited to the rise in application of betamethasone acetate drug to many disease in adults like respiratory disease and renal disease.
On the basis of Distribution Channel, the market of betamethasone acetate is divided into retail pharmacies, hospital pharmacies and online pharmacies. Amongst which, the segment of hospital pharmacies is anticipated to control the market in the predicted period and this is accredited to the rise in number of hospital pharmacies.
In the segment of age group, the segment of elderly (geriatric) in the region of Asia Pacific owing to the rising number of elderly population. For example, in June 2020, as per the data given by the U.S. Census Bureau, till 2020, Asia Pacific had more than 4.5 Bn people which includes people of India and China, both having 1 Bn people, reported for over half the population of the world. The total projected Asians with age above 65 years are 414 Mn, around 20% more than the overall U.S. population which is 331.4 Mn and expected that by the end of the year 2060, more than 1.2 Bn Asians will age above 65 years.
Scilex Holding Company is a subsidiary of Sorrento Therapeutics, Inc., in April 2022, announced the development of its direct distribution network to national as well as regional pharmacies and wholesalers. This development will benefit in raising the sale of the product in all places therefore raises the total effect on the growth of the market.
The main players participating in the market of betamethasone acetate worldwide are Merck & Co., Inc., American Regent, Inc., McKesson Medical-Surgical Inc., GNHIndia.com, Lexicon Medical Supply, Medline Industries, Inc., Caspian Tamin Pharmaceutical Co., Sandoz Canada Inc, NorthWestPharmacy.com Inc., Medisca Inc, Exela Pharma Sciences, LLC, Sanofi Pasteur Inc., Sorrento Therapeutics Inc.
Click Here to Request Customization of this Research Report :
https://www.coherentmarketinsights.com/insight/request-customization/5481
FREQUENTLY ASKED QUALITIES?
➣ What are the Market size for Betamethasone Acetate and its segments?
➣ What are the major drivers, limitations, opportunities, and challenges for the Betamethasone Acetate Market and how can they be expected to affect the Market?
➣ What are the most attractive investment opportunities in the Betamethasone Acetate Market?
➣ What is the Market size for Betamethasone Acetate at the national and regional levels?
➣ What are the growth strategies of the key players in the Betamethasone Acetate Market?
➣ What are the current trends in the Betamethasone Acetate Market? (MandA, partnerships, new product developments, expansions)?
➣ What Market trends are driving the growth in the Betamethasone Acetate Market?
🌍 Trending Reports:
Sustained release coating market
Colombia chile and peru wilsons disease treatment market
Central precocious puberty market
Contact Us :
Mr. Shah
Coherent Market Insights
533 Airport Boulevard, Suite 400,
Burlingame, CA 94010, United States.
U.S.A: +1-206-701-6702
UK: +44-020-8133-4027
JAPAN: +050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com/